Ro Launches Tool to Track Ozempic and Wegovy Shortages
TL;DR Summary
As demand for popular diabetes and weight loss drugs like Wegovy, Zepbound, and Mounjaro outstrips supply, healthcare companies are launching tools to help patients track availability. Telehealth platform Ro has introduced a GLP-1 Supply Tracker, and Eli Lilly is developing a similar tool to provide timely information on drug availability. Despite efforts to ramp up production, shortages are expected to continue in the short term.
- Ozempic and weight loss drug shortages can now be tracked by patients Quartz
- Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages CNBC
- Shortages of Wegovy, Zepbound Lead to Tracking Tool From Ro Bloomberg
- Ro launches Wegovy, Ozempic, GLP-1 tracker Modern Healthcare
- Ozempic and Wegovy are so hard to find that a startup invented a free tool for tracking whether the weight-loss drugs are in stock Fortune
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
2 min
vs 2 min read
Condensed
83%
392 → 65 words
Want the full story? Read the original article
Read on Quartz